Report cover image

Asia Pacific Small Molecule Drug Discovery Market Size and Forecast (2021 - 2031)

Publisher The Insight Partners
Published Jan 14, 2026
SKU # TIP20949556

Description

The Asia Pacific Small Molecule Drug Discovery Market is projected to grow significantly, reaching approximately US$ 18,861.6 million by 2031, up from US$ 8,637.1 million in 2023, reflecting a compound annual growth rate (CAGR) of 10.3% from 2023 to 2031.

Executive Summary and Market Analysis

The small molecule drug discovery market in the Asia Pacific region is divided into several key countries: India, China, Japan, Australia, South Korea, and the Rest of Asia Pacific. Factors driving the growth of this market include advancements in technology, increased collaborations in genomic research between Asian and Western nations, reduced costs of DNA sequencing, and a rising incidence of genetic and other target diseases. The market is also expected to benefit from the growing GDP, which is enhancing the pharmaceutical sector, alongside increasing disposable incomes that are facilitating the adoption of advanced healthcare solutions. These elements indicate a substantial potential for growth in the small molecule drug discovery market.

Strategic Insights

Market Segmentation Analysis
  • By Therapeutic Area: The market is categorized into Oncology, Central Nervous System, Cardiovascular, Respiratory, Orthopedics, Immunology, Rare Diseases, and Other Therapeutic Areas, with Oncology holding the largest market share in 2023.
  • By Process or Phase: The market is segmented into Target Discovery, Target Validation, Lead Generation and Refinement, and Preclinical Development, where Lead Generation and Refinement dominated in 2023.
Market Outlook

In recent years, the pharmaceutical industry has seen a surge in outsourcing services, driven by factors such as the increasing use of small molecules, the complexity of active pharmaceutical ingredients (APIs), and the need to lower development costs. Major pharmaceutical companies are outsourcing research and development (R&D) activities to accelerate drug development and reduce costs. This trend is further supported by the rising complexity in developing new molecular entities (NMEs), which necessitates specialized capabilities that pharmaceutical firms prefer to outsource. The demand for outsourcing is expected to grow as new drug approvals increase, and the clinical development pipeline remains robust. Biotechnology companies are leveraging contract research organizations (CROs) to enhance their small molecule pipelines, and this trend is anticipated to strengthen in the coming years.

CROs provide essential services such as product development, clinical trial support, manufacturing, and commercialization on a contract basis, allowing small molecule drug companies to scale operations and access technical expertise without incurring high overhead costs. This partnership enhances speed to market and cost efficiency, particularly for biologics manufacturers, thereby driving growth in the small molecule drug delivery market.

Country Insights

The Asia Pacific Small Molecule Drug Discovery Market is further analyzed by country, with China holding the largest market share in 2023. As China transitions from a manufacturing-based economy to a service-oriented one, the emphasis on innovation has intensified. The growing population has increased the demand for efficient and cost-effective healthcare solutions. The life sciences and healthcare sectors in China are experiencing robust growth, supported by active mergers and acquisitions among both domestic and international players.

Financial investments from both private and government sectors are expected to further propel the market. China has become an attractive destination for R&D outsourcing, enabling international pharmaceutical companies to reduce product timelines and costs. For instance, the number of clinical trials conducted in China has risen significantly, from around 100 trials per year in 2010 to approximately 350 trials in 2021. This focus on R&D and the expedited clinical trial process are key drivers of market growth in China.

Company Profiles

Key players in the Asia Pacific Small Molecule Drug Discovery Market include GSK Plc, Charles River Laboratories International Inc., Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Co., Merck KGaA, ICON Plc, Revvity Inc., Danaher Corp, Thermo Fisher Scientific Inc., and Oncodesign Services. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to consumers.

Table of Contents

1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. Asia Pacific Small Molecule Drug Discovery Market - Key Market Dynamics
4.1 Market Drivers
4.2 Market Restraints
4.3 Market Opportunities
4.4 Future Trends
4.5 Impact of Drivers and Restraints:
5. Small Molecule Drug Discovery Market - Asia Pacific Market Analysis
5.1 Asia Pacific Small Molecule Drug Discovery Market Revenue (US$ Million), 2023 - 2031
5.2 Asia Pacific Small Molecule Drug Discovery Market Forecast and Analysis
6. Asia Pacific Small Molecule Drug Discovery Market Revenue Analysis - by Therapeutic Area
6.1 Oncology
6.1.1 Overview
6.1.2 Oncology: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.2 Central Nervous System
6.2.1 Overview
6.2.2 Central Nervous System: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.3 Cardiovascular
6.3.1 Overview
6.3.2 Cardiovascular: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.4 Respiratory
6.4.1 Overview
6.4.2 Respiratory: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.5 Orthopedics
6.5.1 Overview
6.5.2 Orthopedics: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.6 Immunology
6.6.1 Overview
6.6.2 Immunology: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.7 Rare Diseases
6.6.1 Overview
6.6.2 Rare Diseases: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
6.8 Other Therapeutic Areas
6.8.1 Overview
6.8.2 Other Therapeutic Areas: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7. Asia Pacific Small Molecule Drug Discovery Market Revenue Analysis - by Process Or Phase
7.1 Target Discovery
7.1.1 Overview
7.1.2 Target Discovery: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Target Validation
7.2.1 Overview
7.2.2 Target Validation: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Lead Generation and Refinement
7.3.1 Overview
7.3.2 Lead Generation and Refinement: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Preclinical Development
7.4.1 Overview
7.4.2 Preclinical Development: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. Asia Pacific Small Molecule Drug Discovery Market - Country Analysis
8.1 Asia Pacific
8.1.1 Asia Pacific Small Molecule Drug Discovery Market Revenue and Forecast and Analysis - by Country
8.1.1.1 Asia Pacific Small Molecule Drug Discovery Market Revenue and Forecast and Analysis - by Country
8.1.2.2 Japan: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.1.2.2.1 Japan: Asia Pacific Small Molecule Drug Discovery Market Share - by Therapeutic Area
8.1.2.2.2 Japan: Asia Pacific Small Molecule Drug Discovery Market Share - by Process Or Phase
8.2.3.3 China: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2.3.3.1 China: Asia Pacific Small Molecule Drug Discovery Market Share - by Therapeutic Area
8.2.3.3.2 China: Asia Pacific Small Molecule Drug Discovery Market Share - by Process Or Phase
8.3.4.4 India: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3.4.4.1 India: Asia Pacific Small Molecule Drug Discovery Market Share - by Therapeutic Area
8.3.4.4.2 India: Asia Pacific Small Molecule Drug Discovery Market Share - by Process Or Phase
8.4.5.5 South Korea: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4.5.5.1 South Korea: Asia Pacific Small Molecule Drug Discovery Market Share - by Therapeutic Area
8.4.5.5.2 South Korea: Asia Pacific Small Molecule Drug Discovery Market Share - by Process Or Phase
8.5.6.6 Australia: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.5.6.6.1 Australia: Asia Pacific Small Molecule Drug Discovery Market Share - by Therapeutic Area
8.5.6.6.2 Australia: Asia Pacific Small Molecule Drug Discovery Market Share - by Process Or Phase
8.6.7.7 Rest of APAC: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.6.7.7.1 Rest of APAC: Asia Pacific Small Molecule Drug Discovery Market Share - by Therapeutic Area
8.6.7.7.2 Rest of APAC: Asia Pacific Small Molecule Drug Discovery Market Share - by Process Or Phase
9 Industry Landscape
9.1 Overview
10 COMPANY PROFILES
10.1 GSK Plc
10.1.1 Key Facts
10.1.2 Business Description
10.1.3 Products and Services
10.1.4 Financial Overview
10.1.5 SWOT Analysis
10.1.6 Key Developments
10.2 Charles River Laboratories International Inc
10.2.1 Key Facts
10.2.2 Business Description
10.2.3 Products and Services
10.2.4 Financial Overview
10.2.5 SWOT Analysis
10.2.6 Key Developments
10.3 Boehringer Ingelheim International GmbH
10.3.1 Key Facts
10.3.2 Business Description
10.3.3 Products and Services
10.3.4 Financial Overview
10.3.5 SWOT Analysis
10.3.6 Key Developments
10.4 Bristol-Myers Squibb Co
10.4.1 Key Facts
10.4.2 Business Description
10.4.3 Products and Services
10.4.4 Financial Overview
10.4.5 SWOT Analysis
10.4.6 Key Developments
10.5 Merck KGaA
10.5.1 Key Facts
10.5.2 Business Description
10.5.3 Products and Services
10.5.4 Financial Overview
10.5.5 SWOT Analysis
10.5.6 Key Developments
10.6 ICON Plc
10.6.1 Key Facts
10.6.2 Business Description
10.6.3 Products and Services
10.6.4 Financial Overview
10.6.5 SWOT Analysis
10.6.6 Key Developments
10.7 Revvity Inc
10.7.1 Key Facts
10.7.2 Business Description
10.7.3 Products and Services
10.7.4 Financial Overview
10.7.5 SWOT Analysis
10.7.6 Key Developments
10.8 Danaher Corp
10.8.1 Key Facts
10.8.2 Business Description
10.8.3 Products and Services
10.8.4 Financial Overview
10.8.5 SWOT Analysis
10.8.6 Key Developments
10.9 Thermo Fisher Scientific Inc.
10.9.1 Key Facts
10.9.2 Business Description
10.9.3 Products and Services
10.9.4 Financial Overview
10.9.5 SWOT Analysis
10.9.6 Key Developments
10.10 Oncodesign Services
10.10.1 Key Facts
10.10.2 Business Description
10.10.3 Products and Services
10.10.4 Financial Overview
10.10.5 SWOT Analysis
10.10.6 Key Developments
11. Appendix
11.1 About The Insight Partners
LIST OF TABLES
Table 1. Asia Pacific Small Molecule Drug Discovery Market Segmentation
Table 3. Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Therapeutic Area
Table 5. Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Process Or Phase
Table 6. Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 7. Japan: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Therapeutic Area
Table 8. Japan: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Process Or Phase
Table 9. China: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Therapeutic Area
Table 10. China: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Process Or Phase
Table 11. India: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Therapeutic Area
Table 12. India: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Process Or Phase
Table 13. South Korea: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Therapeutic Area
Table 14. South Korea: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Process Or Phase
Table 15. Australia: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Therapeutic Area
Table 16. Australia: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Process Or Phase
Table 17. Rest of APAC: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Therapeutic Area
Table 18. Rest of APAC: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Process Or Phase
Table 19. Heat Map Analysis by Key Players
LIST OF FIGURES
Figure 1. Asia Pacific Small Molecule Drug Discovery Market Segmentation - Country
Figure 4. Asia Pacific Small Molecule Drug Discovery Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Asia Pacific Small Molecule Drug Discovery Market Revenue (US$ Million), 2023 - 2031
Figure 7. Asia Pacific Small Molecule Drug Discovery Market Share (%) - by Therapeutic Area, 2023 and 2031
Figure 8. Oncology: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. Central Nervous System: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Cardiovascular: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Respiratory: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Orthopedics: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Immunology: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 14. Rare Diseases: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. Other Therapeutic Areas: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Asia Pacific Small Molecule Drug Discovery Market Share (%) - by Process Or Phase, 2023 and 2031
Figure 17. Target Discovery: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Target Validation: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Lead Generation and Refinement: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 20. Preclinical Development: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Asia Pacific Small Molecule Drug Discovery Market Breakdown by Key Countries, 2023 and 2031 (%)
Figure 22. Japan: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 23. China: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. India: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. South Korea: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Australia: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Rest of APAC: Asia Pacific Small Molecule Drug Discovery Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Company Positioning & Concentration

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us